Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pertussis toxin (PT) is a protein exotoxin produced by *Bordetella pertussis*. It is an AB5 toxin that disrupts cell signaling by ADP-ribosylating Giα proteins, leading to increased intracellular cAMP levels. This disruption contributes to the pathogenesis of whooping cough and modulates the host immune response. It is used as a research tool and genetically inactivated forms are used in vaccines.
ADP-ribosylates Giα proteins, leading to increased intracellular cAMP levels and disrupted cell signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pertussis Toxin (PT).